疫苗可预防疾病监测成本研究的系统综述
多数研究旨在估算新增监测成分的增量成本,人员成本为最大成本驱动因素,占总监测成本的21%至61%。
要点
- 人员成本是最大成本驱动因素,占21%至61%。
- 实验室监测成本、共享资源成本核算及资本成本数据存在关键缺口。
核心结论
- 该综述为中低收入国家投资和倡导更稳健的VPD监测系统提供了起点。
- 识别出关键缺口:实验室监测成本信息有限、共享资源成本核算困难、资本成本数据缺失。
- 需要适当指南指导中低收入国家开展VPD监测系统成本研究。
研究设计与样本
- 系统综述,检索PubMed、Web of Science、EconLit及Google灰色文献。
- 研究覆盖6个低收入国家、2个中低收入国家和3个中等收入国家。
主要发现
- 多数研究旨在估算新增监测成分的增量成本。
- VPD监测系统成本以每资源类别、卫生结构层级和VPD监测活动的年均成本呈现。
- 人员时间/人员成本为最大成本驱动因素,在9项识别成本驱动因素的研究中占总VPD监测系统成本的21%至61%。
临床怎么用
- 为中低收入国家规划和倡导VPD监测系统投资提供成本信息参考。
- 提示开展VPD监测成本研究时应关注人员成本、实验室监测成本及资本成本。
局限性
- 实验室监测成本信息有限。
- 共享资源成本核算存在挑战。
- 资本成本数据缺失。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Planning and monitoring vaccine introduction and effectiveness relies on strong vaccine-preventable disease (VPD) surveillance. In low and middle-income countries (LMICs) especially, cost is a commonly reported barrier to VPD surveillance system maintenance and performance; however, it is rarely calculated or assessed. This review describes and compares studies on the availability of cost information for VPD surveillance systems in LMICs to facilitate the design of future cost studies of VPD surveillance. METHODS: PubMed, Web of Science, and EconLit were used to identify peer-reviewed articles and Google was searched for relevant grey literature. Studies selected described characteristics and results of VPD surveillance systems cost studies performed in LMICs. Studies were categorized according to the type of VPD surveillance system, study aim, the annual cost of the system, and per capita costs. RESULTS: Eleven studies were identified that assessed the cost of VPD surveillance systems. The studies assessed systems from six low-income countries, two low-middle-income countries, and three middle-income countries. The majority of the studies (n = 7) were conducted in sub-Saharan Africa and fifteen distinct VPD surveillance systems were assessed across the studies. Most studies aimed to estimate incremental costs of additional surveillance components and presented VPD surveillance system costs as mean annual costs per resource category, health structure level, and by VPD surveillance activity. Staff time/personnel cost represents the largest cost driver, ranging from 21% to 61% of total VPD surveillance system costs across nine studies identifying a cost driver. CONCLUSIONS: This review provides a starting point to guide LMICs to invest and advocate for more robust VPD surveillance systems. Critical gaps were identified including limited information on the cost of laboratory surveillance, challenges with costing shared resources, and missing data on capital costs. Appropriate guidance is needed to guide LMICs conducting studies on VPD surveillance system costs.
引用
- Erondu NA, Ferland L, Haile BH, et al. A systematic review of vaccine preventable disease surveillance cost studies. Vaccine. 2019. PMID: 30902482. doi:10.1016/j.vaccine.2019.02.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。